Cutis develops microbiome-based skincare ingredients
They use genomics and assays to identify beneficial bacteria strains and postbiotics that suppress pathogens, reduce inflammation, and strengthen skin barriers without antibiotics.
See the latest news and media coverage for Cutis. We track all announcements, press releases, and industry mentions in real time, all in one place.
Skin microbiome biotech company
cutis.seLast updated
In short: Cutis advanced its Reborn SkinBiome platform, joined the Sting Core Program 2025, and prepared for the SLUSH 2025 investor conference.
They use genomics and assays to identify beneficial bacteria strains and postbiotics that suppress pathogens, reduce inflammation, and strengthen skin barriers without antibiotics.
Reborn SkinBiome™ platform identifies commensal strains and postbiotics to treat acne, eczema, and rosacea without antibiotics, addressing resistance.
The acceptance provides access to investors, coaches, and experts. It supports Cutis in revolutionizing skin health through the microbiome.
The biotechnology platform uses live commensal bacteria to restore skin resilience, based on research from Karolinska Institutet and four core pillars. Cutis seeks partnerships.
A fun and inspiring adventure begins when CUTIS comes up with a unique way to earn what he needs for a special feast planned for...
A funny and chaotic moment unfolds when CUTIS is left alone to babysit Buem without any help. What seems like a simple responsibility quickly turns...
CUTIS finds themselves in a hilarious situation after secretly doing something unexpected at home. What begins as a quiet and hidden action quickly turns into...
Cutis Lab has incorporated cannabidiol (CBD) as the main ingredient in a range of products aimed at daily skin care, the scalp...
Track Cutis and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.